Fine Foods & Pharmaceuticals NTM SpA
MIL:FF

Watchlist Manager
Fine Foods & Pharmaceuticals NTM SpA Logo
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Watchlist
Price: 7.94 EUR -0.25% Market Closed
Market Cap: 194.5m EUR
Have any thoughts about
Fine Foods & Pharmaceuticals NTM SpA?
Write Note

Fine Foods & Pharmaceuticals NTM SpA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fine Foods & Pharmaceuticals NTM SpA
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Operating Income
€16.9m
CAGR 3-Years
8%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Stevanato Group SpA
NYSE:STVN
Operating Income
€213m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Fine Foods & Pharmaceuticals NTM SpA
Glance View

Market Cap
194.4m EUR
Industry
Life Sciences Tools & Services

Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 768 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.

FF Intrinsic Value
16.27 EUR
Undervaluation 51%
Intrinsic Value
Price

See Also

What is Fine Foods & Pharmaceuticals NTM SpA's Operating Income?
Operating Income
16.9m EUR

Based on the financial report for Jun 30, 2024, Fine Foods & Pharmaceuticals NTM SpA's Operating Income amounts to 16.9m EUR.

What is Fine Foods & Pharmaceuticals NTM SpA's Operating Income growth rate?
Operating Income CAGR 5Y
1%

Over the last year, the Operating Income growth was 83%. The average annual Operating Income growth rates for Fine Foods & Pharmaceuticals NTM SpA have been 8% over the past three years , 1% over the past five years .

Back to Top